AnandRathi

Remus Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 23 Sept 2026
966.95
+15.80 (+1.66%)

Remus Pharmaceuticals Ltd (Remus Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹1,121 crore.

Remus Pharmaceuticals Ltd Overview

Market cap₹1,121 Crs
Volume7,600
Prev. Close₹951.15
Year range₹580.00 - ₹1,007.00
ISININE0O5T01011

Remus Pharmaceuticals Ltd Fundamentals

ROCE(TTM)10.19%
P/E Ratio (TTM)45.36
P/B Ratio3.44
Debt to Equity0.02
ROE7.59%
EPS (TTM)20.97
Dividend Yield0.05%
Book Value276.40
Profit Margin0.00%
Operating Margin0.00%

Remus Pharmaceuticals Ltd Historical Performance

1 Month Return-1.09%
6 Month Return56.75%
3 Year Return66.31%
3 Month Return21.44%
1 Year Return19.12%
5 Year Return-

Remus Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research